Baran-Rajasthan, India

Mohan Lal Mehta

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Pi Industries Ltd.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mohan Lal Mehta: Innovator in Fungicidal Compounds

Introduction

Mohan Lal Mehta is an inventor based in Baran, Rajasthan, India. He is currently associated with Pi Industries Ltd., where he contributes to the development of innovative solutions in the field of fungicidal compounds. Although he has not yet been granted any patents, his work is focused on creating novel chemical formulations that have the potential to impact agricultural practices.

Latest Patent Applications

Mohan Lal Mehta has submitted several patent applications that showcase his innovative approach. One of his latest applications is titled "Novel Sulfilimines or Sulfoximines Containing Fungicidal Heterocyclic Compounds." This invention relates to a compound formula (I) and a process for preparing the same, wherein R, A, E, Hy, R, n, Q, and W are each defined in the description. The invention also includes the combination and composition comprising the compound of formula (I).

Another significant application is "Novel Fungicidal Heterocyclic Compounds." This invention pertains to a compound selected from Formula I and a process for preparing the same, with R, T, L, A, G, J, n, W, Z, and Z defined in the description. Similar to the previous application, it also relates to the combination and composition comprising the compound of Formula I.

Conclusion

Mohan Lal Mehta is a dedicated inventor whose work in fungicidal compounds holds promise for advancements in agricultural chemistry. His innovative patent applications reflect his commitment to developing effective solutions in this field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…